Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.68 $0.02 (3%) RKDA stock closing price Apr 27, 2017 (Closing)

The Arcadia Biosciences cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows Arcadia Biosciences profits, the balance sheet shows Arcadia Biosciences debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. This statement can tell if a company is running out of money while still being profitable and is useful in Arcadia Biosciences stock analysis. Arcadia Biosciences had a negative net income cash flow of $-19.62M for the latest year. This report is very useful in measuring the short term viability of a company. RKDA increase in investments stood at a negative value of $-5.3M for the latest 2016. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2016 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
-19.62M-17.95M-18.33M-13.19M
Depreciation Depletion Amortization Cash-Flow0.44M0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities0.86M-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations----
Other Adjustments Net1.26M2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-17.05M-15.1M-14.78M-9.74M
Increase (Decrease) in Prop Plant And Equipment-0.23M-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires---1.45M-0.5M
Increase (Decrease) in Investments-5.07M-46.21M--
Other Cash Inflow (Outflow) from Investment Activities----
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-5.3M-46.36M-1.59M-0.6M
Issuance (Purchase) of Equity Shares0.44M68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities-10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
0.39M68.87M30.11M7.83M
Effect of Exchange Rate Changes on Cash----
Arcadia Biosciences Net Change in Cash & Cash Equivalents
-21.96M7.4M13.73M-2.51M
Cash & Equivalents at Beginning of Year23.97M16.57M2.83M5.35M
Cash & Equivalents at Year End2.01M23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

While Arcadia Biosciences stock price history provides the price history of a stock, Arcadia Biosciences stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Net Change in Cash and Cash Equivalents: Arcadia Biosciences cash reduced YoY to $-19.62M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Arcadia Biosciences stock price movement.
  • The cash generated from the core business or operations was negative at $-17.05M for Arcadia Biosciences in the latest year. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-17.05M for RKDA in last year report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $0.39M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-7.94